Active Ingredient: PEGCETACOPLAN
Proprietary Name: SYFOVRE
Dosage Form; Route of Administration: SOLUTION; INTRAVITREAL
Strength: 15MG/0.1ML (15MG/0.1ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N217171
Product Number: 001
Approval Date: Feb 17, 2023
Applicant Holder Full Name: APELLIS PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
